Abstract
MRP, a gene recently isolated from a non-P-glycoprotein-mediated multidrug-resistant small cell lung cancer line, is a candidate multidrug-resistance gene. Mitoxantrone, an anthracenedione antitumor agent, frequently selects for non-P-glycoprotein-mediated multidrug resistance in in vitro models. To determine whether mitoxantrone-selected multidrug resistance wasdue to overexpression of MRP, we examined the expression of MRP in four mitoxantrone-selected, multidrug-resistant human tumor cell lines, using a reverse transcriptase/polymerase chain reaction assay. Results from these experiments suggest that overexpression of MRP does not appear to play a primary role in mitoxantrone-selected multidrug resistance in these cell lines, and that other novel drug-resistance mechanisms are likely.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1601-1606 |
| Number of pages | 6 |
| Journal | Biochemical Pharmacology |
| Volume | 47 |
| Issue number | 9 |
| DOIs | |
| State | Published - Apr 29 1994 |
Keywords
- MRP
- PCR
- drug resistance
- human tumor cell lines
- mRNA
- mitoxantrone
ASJC Scopus subject areas
- Biochemistry
- Pharmacology
Fingerprint
Dive into the research topics of 'Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS